A novel treatment regimen of granulocyte colony-stimulating factor combined with ultra-low-dose decitabine and low-dose cytarabine in older patients with acute myeloid leukemia and myelodysplastic syndromes

BACKGROUND: Older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) unfit for intensive chemotherapy are emergent for suitable treatment strategies. Hypomethylating agents and low-dose cytarabine have generated relevant benefits in the hematological malignancies over rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Huan, Yang, Bin, Liu, Jia, Wang, Biao, Wu, Yicun, Zheng, Zhuojun, Ling, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111530/
https://www.ncbi.nlm.nih.gov/pubmed/33995987
http://dx.doi.org/10.1177/20406207211009334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111530/
https://www.ncbi.nlm.nih.gov/pubmed/33995987
http://dx.doi.org/10.1177/20406207211009334

Ejemplares similares